Case study · GLP-1 and body composition
Preserving lean mass through and beyond GLP-1 therapy
A woman in her early 40s lost about 48 pounds, roughly 27% of her starting weight, with tirzepatide and nutrition care. This case is about what came after the weight number: the point where muscle, not the scale, decided what her dietitian did next.
De-identified case study · Published
At a glance
~48 lb
total weight reduction
~27%
of starting body weight
~32.7 → ~24.0
BMI, into the healthy range
~0.79
current waist-to-hip ratio
- Profile
- Woman in her early 40s, 5 ft 2 in, working full time on a demanding schedule
- Starting weight
- About 179 lb (BMI about 32.7, obesity class I)
- Current weight
- About 131 lb (BMI about 24.0, healthy range)
- Medication
- Tirzepatide (Zepbound), prescribed by her physician and since stopped
- Body composition
- Measured throughout; about 1 lb of skeletal muscle loss in the most recent interval
- Current phase
- Weight maintenance and nutritional adequacy; further weight loss is no longer a goal
Why this case is worth reading
Most GLP-1 stories end at the weight number. This one turns on what happened after it, when her dietitian stopped pushing toward the scale and turned the plan around.
Tirzepatide produced a large and lasting weight reduction. But the appetite suppression that made it work did not switch off when the medication stopped. She kept eating well below her planned portions and often left protein unfinished.
Repeat body composition testing picked up about a pound of skeletal muscle loss over a single interval. That finding, not her weight, decided what happened next.
Where she started
She came for medical nutrition therapy to lose weight and improve her metabolic health, while her physician prescribed tirzepatide.
She worked full time in a role with short, irregular meal breaks. She was an engaged patient by any measure: she cooked at home, carried lunch to work, kept to the agreed eating structure and chose food sensibly throughout.
What the assessment found
Food quality was never the problem. The problem was how much she could eat, and which part of the plate she left behind.
Measurements now
- Weight about 131 lb, down from about 179 lb
- BMI about 24.0, down from about 32.7
- Waist about 81 cm, hip about 102 cm, waist-to-hip ratio about 0.79
- Abdominal circumference about 89 cm, taken while bloated, so treated as provisional until it is repeated in the morning, fasted
Needs in this phase
Energy was set at about 1,500 calories a day, for maintenance rather than a deficit. Protein was set at about 90 grams a day, spread across meals: a deliberately protein-forward target to protect lean mass.
How she was eating
Her usual foods included eggs, lean meat and chicken, fish, vegetables, fruit, Greek yogurt and modest portions of pasta or bread. But portions came in smaller than planned, fullness arrived mid-meal, and because she ate vegetables first, protein was the part most often left on the plate.
Other context
She had recently had abdominal surgery. Recovery was uncomplicated apart from a skin reaction at the incision sites, which her surgical team was managing. Her sleep was disrupted that week, though her daytime energy and mood stayed good.
The problem had turned upside down
At the start, the problem was eating too much. At this visit it was the opposite: too little protein and energy, from appetite suppression that outlasted the medication and a workday that cut meals short.
The evidence was clear in the record: portions consistently below the plan, protein routinely unfinished, and a measured loss of skeletal muscle. That reversal is the whole clinical story.
What her dietitian changed
Six changes, each aimed at protecting muscle rather than taking off more weight.
- The goal changed on paper. Further weight loss came off the plan and energy was reset to maintenance. After losing 27% of her body weight, with an appetite that had not recovered, "keep going" was not a neutral instruction.
- Protein comes first on the plate. The order of eating was reversed so that early fullness no longer costs her the protein, with about 90 grams spread through the day.
- Quantity became the measure. She already knew what to eat; counseling turned to how much, and to finishing what was served.
- The workday was planned around the constraint: Greek yogurt with chia and berries, protein powder where it fits, grilled chicken salads, small prepared meals and a stocked office fridge, so a short break never becomes a skipped meal.
- Tracking now follows the right things: weight, appetite, meal completion, energy, sleep, digestion and body composition, with measurements taken under the same conditions each time.
- Care stays coordinated. Her surgical team follows the incision-site reaction, and pending lab work will be reviewed when it arrives, with any shortfall treated on the results rather than on assumption.
Where she is now
She has kept off about 48 pounds since stopping tirzepatide, and the muscle loss was caught early and acted on.
- About 48 pounds lost (about 179 lb to about 131 lb), roughly 27% of her starting body weight
- BMI moved from the obesity class I range into the healthy range (about 32.7 to about 24.0)
- Waist-to-hip ratio about 0.79, below the level linked to higher heart and metabolic risk in women
- Weight held after tirzepatide stopped: her eating pattern, not the medication, now carries the result
- About a pound of skeletal muscle loss in one interval changed the plan before it could compound
- Energy and mood good throughout, including a week of poor sleep and post-surgical discomfort
What this case shows
Stopping a GLP-1 medication does not end the nutrition risk. For many people it starts the most important stretch, just as structured support often ends.
Appetite suppression can outlast the prescription
Her intake stayed below target after tirzepatide stopped.
The scale is the wrong instrument for this job
A 48-pound loss looks like plain success. Only repeat body composition testing showed that some of it was coming from muscle. Without it, the plan would not have changed.
Protein first answers early fullness
When fullness arrives before the plate is finished, the order of eating decides what gets left. Vegetables first is sound advice in a deficit and works against you in this phase.
Knowing how to eat well is not the same as being able to
Her food choices were excellent from the start. What limited her was fullness and a work schedule, and neither responds to more advice about food choice.
About this case study
This case study comes from one person’s clinical record and is published with her written consent. Identifying details have been removed or generalized.
It describes one person’s course, not typical results. Response to GLP-1 medication, the pace of weight loss and changes in body composition vary widely from person to person, and nothing here is a guarantee of any outcome.
Blood sugar markers are not reported. Lab work was drawn at this visit and the results were still pending, so no before-and-after values were available and none have been estimated.
Weight, body composition and circumference figures are as recorded. The circumference measurements were taken while bloated and are marked as provisional until repeated under the same conditions.
This is general education, not medical advice. Tirzepatide is a prescription medication: whether to start it, how much to take and when to stop are decisions for the prescribing clinician.